Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jan 17 2024

Full Issue

Perspectives: Will Importing Prescriptions Lower The Cost?; PCPs Should Be Treating Opioid Use Disorder

Read recent commentaries about pharmaceutical issues.

Bloomberg: Florida Wants To Import Prescription Drugs. Good Luck

The US pays 50% more per capita for prescription drugs than Canada. Frustrated by this discrepancy, a handful of states in recent years have developed plans to import cheaper medications from across the border. Florida recently became the first state to get approval from the Food and Drug Administration to do so. (1/16)

South Florida Sun Sentinel: Like Canada, U.S. Should Control Drug Prices 

Canada too has a powerful pharmaceutical lobby. According to news reports, it has stifled the review board’s most recent price-control undertakings. The director and two board members resigned, with one of them blaming the Canadian government for surrendering to industry pressure. The important difference is still that Canada has comprehensive price controls, however effective they may be, and the U.S. does not. Our consumers will continue to be stiffed until we have them too. (1/15)

New England Journal of Medicine: Treating Opioid Use Disorder In General Practice — Diagnosis, Harm Reduction, And Medications 

In this Double Take video from the New England Journal of Medicine and NEJM Knowledge+, L.J. Punch (the T St. Louis, a harm-reduction program), Sarah Bagley (Boston Medical Center), Jennifer Foreman (Randolph Health Medical Group), and Scott Hadland (Massachusetts General Hospital for Children) review how primary care providers can best care for patients with opioid use disorder. They guide clinicians on how to diagnose the disorder, build trust with patients, offer counseling on harm reduction, and use medications to treat addiction and withdrawal symptoms. (Sarah Bagley, M.D., et al, 1/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF